181 related articles for article (PubMed ID: 25975416)
21. Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort.
Swede H; Hajduk AM; Sharma J; Rawal S; Rasool H; Vella AT; Tobet RE; Stevens RG
Int J Cancer; 2014 Apr; 134(8):1862-70. PubMed ID: 24122448
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of smoking in addition to established risk factors in patients with Dukes B and C colorectal cancer: a retrospective analysis.
Diamantis N; Xynos ID; Amptulah S; Karadima M; Skopelitis H; Tsavaris N
J BUON; 2013; 18(1):105-15. PubMed ID: 23613395
[TBL] [Abstract][Full Text] [Related]
23. Pattern of relapse after curative surgery for metastatic colorectal cancer.
You JJ; Chen HC; Chen HJ; Hsieh CS; Chang MC; Yu JH; Chen YL; Chang CS
Saudi Med J; 2011 Sep; 32(9):907-12. PubMed ID: 21894352
[TBL] [Abstract][Full Text] [Related]
24. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
[TBL] [Abstract][Full Text] [Related]
25. Circulating tumor cells count predicts survival in colorectal cancer patients.
Romiti A; Raffa S; Di Rocco R; Roberto M; Milano A; Zullo A; Leone L; Ranieri D; Mazzetta F; Medda E; Sarcina I; Barucca V; D'Antonio C; Durante V; Ferri M; Torrisi MR; Marchetti P
J Gastrointestin Liver Dis; 2014 Sep; 23(3):279-84. PubMed ID: 25267956
[TBL] [Abstract][Full Text] [Related]
26. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer.
Mekenkamp LJ; Heesterbeek KJ; Koopman M; Tol J; Teerenstra S; Venderbosch S; Punt CJ; Nagtegaal ID
Eur J Cancer; 2012 Mar; 48(4):501-9. PubMed ID: 22226571
[TBL] [Abstract][Full Text] [Related]
27. Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.
Ahmed S; Fields A; Pahwa P; Chandra-Kanthan S; Zaidi A; Le D; Haider K; Reeder B; Leis A
Clin Colorectal Cancer; 2015 Dec; 14(4):e41-7. PubMed ID: 26140732
[TBL] [Abstract][Full Text] [Related]
28. Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials.
Faron M; Pignon JP; Malka D; Bourredjem A; Douillard JY; Adenis A; Elias D; Bouché O; Ducreux M
Eur J Cancer; 2015 Jan; 51(2):166-76. PubMed ID: 25465185
[TBL] [Abstract][Full Text] [Related]
29. Effect of body mass index on survival after curative therapy for non-B non-C hepatocellular carcinoma.
Nishikawa H; Osaki Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Arimoto A; Kita R; Kimura T
J Gastrointestin Liver Dis; 2013 Jun; 22(2):173-81. PubMed ID: 23799216
[TBL] [Abstract][Full Text] [Related]
30. Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer.
Blauwhoff-Buskermolen S; Versteeg KS; de van der Schueren MA; den Braver NR; Berkhof J; Langius JA; Verheul HM
J Clin Oncol; 2016 Apr; 34(12):1339-44. PubMed ID: 26903572
[TBL] [Abstract][Full Text] [Related]
31. Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.
Ahmed S; Leis A; Fields A; Chandra-Kanthan S; Haider K; Alvi R; Reeder B; Pahwa P
Cancer; 2014 Mar; 120(5):683-91. PubMed ID: 24222180
[TBL] [Abstract][Full Text] [Related]
32. Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III).
Schmoll HJ; Cunningham D; Sobrero A; Karapetis CS; Rougier P; Koski SL; Kocakova I; Bondarenko I; Bodoky G; Mainwaring P; Salazar R; Barker P; Mookerjee B; Robertson J; Van Cutsem E
J Clin Oncol; 2012 Oct; 30(29):3588-95. PubMed ID: 22965961
[TBL] [Abstract][Full Text] [Related]
33. Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study).
Caan BJ; Meyerhardt JA; Kroenke CH; Alexeeff S; Xiao J; Weltzien E; Feliciano EC; Castillo AL; Quesenberry CP; Kwan ML; Prado CM
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1008-1015. PubMed ID: 28506965
[No Abstract] [Full Text] [Related]
34. Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.
Varkaris A; Katsiampoura A; Davis JS; Shah N; Lam M; Frias RL; Ivan C; Shimizu M; Morris J; Menter D; Overman M; Tran H; Heymach J; Chun YS; Vauthey JN; Calin G; Kopetz S
Br J Cancer; 2019 Feb; 120(3):340-345. PubMed ID: 30636774
[TBL] [Abstract][Full Text] [Related]
35. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies.
De Vita F; Orditura M; Galizia G; Romano C; Infusino S; Auriemma A; Lieto E; Catalano G
Cancer; 1999 Nov; 86(10):1936-43. PubMed ID: 10570416
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab.
Nissen NI; Kehlet S; Boisen MK; Liljefors M; Jensen C; Johansen AZ; Johansen JS; Erler JT; Karsdal M; Mortensen JH; Høye A; Willumsen N
Sci Rep; 2021 Jan; 11(1):865. PubMed ID: 33441622
[TBL] [Abstract][Full Text] [Related]
37. Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis.
Lin MS; Huang JX; Zhu J; Shen HZ
Hepatogastroenterology; 2012 Sep; 59(118):1687-90. PubMed ID: 22591645
[TBL] [Abstract][Full Text] [Related]
38. Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centre.
Daniel CR; Shu X; Ye Y; Gu J; Raju GS; Kopetz S; Wu X
Br J Cancer; 2016 Jan; 114(1):103-9. PubMed ID: 26679375
[TBL] [Abstract][Full Text] [Related]
39. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
[TBL] [Abstract][Full Text] [Related]
40. High preoperative serum ferritin predicted poor prognosis in non-metastatic colorectal cancer.
Tingting H; Di S; Xiaoping C; Xiaohong W; Dong H
Saudi Med J; 2017 Mar; 38(3):268-275. PubMed ID: 28251222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]